Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Vaccines

  Free Subscription


05.10.2026

1 BMJ
3 Clin Infect Dis
3 J Immunol
2 J Infect
1 J Infect Dis
1 J Virol
1 JAMA
1 N Engl J Med
1 Nat Immunol
1 Pediatr Rev
3 PLoS One
2 Proc Natl Acad Sci U S A
25 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. TANNE JH
    Trump's latest pick for FDA head backs president over vaccines and vapes.
    BMJ. 2026;394:e100991.
    PubMed        


    Clin Infect Dis


  2. Correction to: Wanted: A Relevant Correlate of Protection for Dengue Vaccines.
    Clin Infect Dis. 2026 Sep 30:ciag606. doi: 10.1093.
    PubMed        

  3. SHI MA, Han J, Albahra R, Machicao MF, et al
    Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study.
    Clin Infect Dis. 2026 Sep 29:ciag585. doi: 10.1093.
    PubMed         Abstract available

  4. KRISHNAN G, Kottilil S
    Closing the Hepatitis B Vaccination Gap in Liver Transplant Candidates.
    Clin Infect Dis. 2026 Sep 29:ciag586. doi: 10.1093.
    PubMed        


    J Immunol

  5. NGUYEN NDNT, Guleed S, Subratheepam S, Marcos-Lopez E, et al
    CTH522/CAF01 vaccination elicits clonally related Th17 subsets that mediate IL-17A-dependent protection against Chlamydia trachomatis.
    J Immunol. 2026;215:vkag265.
    PubMed         Abstract available

  6. ISHIZUKA AS, Garliss CM, Goddu RN, Merolle M, et al
    Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.
    J Immunol. 2026;215:vkag232.
    PubMed         Abstract available

  7. BRAVERMAN J, Monk IR, To MA, Wang N, et al
    Live versus killed Listeria monocytogenes immunization differentially programs Hup-specific CD4+ T cell responses with distinct protective outcomes.
    J Immunol. 2026;215:vkag253.
    PubMed         Abstract available


    J Infect

  8. NAZARETH J, Martin CA, Pan D, Barr IG, et al
    Ethnic differences in inactivated influenza vaccine immunogenicity in UK Healthcare Workers: A two-year prospective longitudinal study.
    J Infect. 2026 Sep 29:106862. doi: 10.1016/j.jinf.2026.106862.
    PubMed         Abstract available

  9. GROENVELD MA, Visser DH, Brouwer MC, Jamrozy D, et al
    Clinical characteristics, outcomes and molecular epidemiology of group B streptococcal disease in young infants in the Netherlands.
    J Infect. 2026;93:106815.
    PubMed         Abstract available


    J Infect Dis

  10. MUSINGUZI K, Sbarra AN, Bach F, Nankya F, et al
    Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants.
    J Infect Dis. 2026 Sep 28:jiag488. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  11. ZHANG Y, Holly J, Gibbs J, Yewdell JW, et al
    Real-time tracking of vaccinia virus entry using a split luciferase complementation assay.
    J Virol. 2026 Sep 29:e0111526. doi: 10.1128/jvi.01115.
    PubMed         Abstract available


    JAMA

  12. ANDERER S
    Societies Release Vaccine Recommendations for Respiratory Virus Season.
    JAMA. 2026 Oct 2. doi: 10.1001/jama.2026.20006.
    PubMed        


    N Engl J Med

  13. HARRIS GH, Sinchi A, Lawler J, Frank M, et al
    Andes Virus - A Clinical Review.
    N Engl J Med. 2026;395:1310-1317.
    PubMed         Abstract available


    Nat Immunol

  14. LIM K, Dahal A, Lv X, Kim KD, et al
    Monocyte-derived galectin-1(hi) cells provide innate immune help in the generation of functional memory CD8(+) T cells.
    Nat Immunol. 2026;27:2102-2116.
    PubMed         Abstract available


    Pediatr Rev

  15. WILLIAMS A, Dehority W
    Recognizing a Few of the Vaccine-Preventable Diseases: Part 2.
    Pediatr Rev. 2026;47:547-556.
    PubMed        


    PLoS One

  16. LIU H, Zhu Z, Liu Y, Wang J, et al
    Evaluation of the real-world protective effect of mumps-containing vaccines among children under 15 years old in Taizhou: A 1:2 matched case-control study.
    PLoS One. 2026;21:e0359417.
    PubMed         Abstract available

  17. SHAH SSAM, Al-Ani HAM, Alwardi MAW, Zehra A, et al
    Immunization timeliness and its determinants among young children in Baghdad, Iraq: A cross-sectional study using documented vaccination cards.
    PLoS One. 2026;21:e0359962.
    PubMed         Abstract available

  18. NEVES RKAD, Bastos LS, Maciel Villela DA, Saraceni V, et al
    Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.
    PLoS One. 2026;21:e0332281.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  19. OVESON A, Gumel AB
    Projected effects of removing school-entry vaccination requirements on measles transmission in Florida.
    Proc Natl Acad Sci U S A. 2026;123:e2610455123.
    PubMed         Abstract available

  20. HOGARTY MP, Li H, Zhao C, Martella CL, et al
    Deletions in variable region 1 of the HIV envelope accelerate V3-glycan bNAb induction in SHIV-infected rhesus macaques.
    Proc Natl Acad Sci U S A. 2026;123:e2620354123.
    PubMed         Abstract available


    Vaccine

  21. RIHS JB, Duval IB, Amorim CCO, Pinto JC, et al
    Engineered invasive Lactococcus lactis as an oral vaccine delivery platform is associated with compartmentalized immune modulation and enhances control of Leishmania infantum infection.
    Vaccine. 2026;93:129218.
    PubMed         Abstract available

  22. SHICHINOHE S, Li Q, Tanaka H, Anindita J, et al
    Cross-clade protection against human H5N1 isolates by a clade 2.3.4.4b HA mRNA vaccine in mice.
    Vaccine. 2026;93:129215.
    PubMed         Abstract available

  23. DINIZ LLCL, Santos DO, Maffetano CV, Taguchi NT, et al
    A multi-antigen chimeric PvCSP-MSP1(19) vaccine induces robust humoral responses against distinct stages of Plasmodium vivax.
    Vaccine. 2026;93:129197.
    PubMed         Abstract available

  24. GOULD S, Rohde CM, Destexhe E, Tiesjema B, et al
    Summary of 2025 Society of Toxicology Workshop "Vaccine Toxicology in the Post-COVID Era".
    Vaccine. 2026;93:129180.
    PubMed         Abstract available

  25. BANISAEED SR, Rasooli I, Ghazanfari T, Ajdary S, et al
    An integrated immunoinformatics and experimental pipeline identifies an LCL-scaffolded OmpA loop 3 construct as a protective vaccine candidate against Acinetobacter baumannii.
    Vaccine. 2026;93:129205.
    PubMed         Abstract available

  26. MOZAFFARI F, Aung ET, Soe NN, Wijekoon D, et al
    Validation of self-reported mpox vaccination in men who have sex with men.
    Vaccine. 2026;93:129193.
    PubMed         Abstract available

  27. ARROYO L, Raeman R, Iyer SS
    Acute immunometabolic reprogramming following clade C HIV immunization in rhesus macaques.
    Vaccine. 2026;92:129115.
    PubMed         Abstract available

  28. DENG L, Ye X, Chen X, Hu X, et al
    Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.
    Vaccine. 2026;92:129118.
    PubMed         Abstract available

  29. BAZARJAV P, Erdene-Ochir T, Sandagdorj A, Enkhtuvshin A, et al
    One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.
    Vaccine. 2026;93:129179.
    PubMed         Abstract available

  30. FERNANDEZ-VEIGA L, Elguezabal N, Fuertes M, Geijo MV, et al
    Pathological, microbiological and immunological performance of three tuberculosis vaccine candidates in goats.
    Vaccine. 2026;93:129196.
    PubMed         Abstract available

  31. CHAULAGAIN S, Werner AP, Parish MA, Talukdar SN, et al
    Sex differences in vaccine-induced neuraminidase cross-recognition impact H5N1 dissemination to the lower respiratory tract in mice.
    Vaccine. 2026;93:129189.
    PubMed         Abstract available

  32. PATIL DY, Sahay RR, Shete AM, Mohandas S, et al
    Development and internal analytical validation of plaque reduction neutralization test for clinical trial application of Kyasanur forest disease virus vaccine.
    Vaccine. 2026;93:129206.
    PubMed         Abstract available

  33. MONTES CAMINO LM, Aldea M, Martinez C, Garcia-Basteiro AL, et al
    Evaluation of the immunogenicity of hepatitis B vaccination in hematopoietic stem cell transplant recipients vaccinated with a hexavalent vaccine compared with patients vaccinated with a combined hepatitis A and B vaccine.
    Vaccine. 2026;93:129183.
    PubMed         Abstract available

  34. HUETE-CARRASCO J, Aboagye J, Neple D, McClean S, et al
    Cationic surfactant-dependent enhancement of antigen-specific cellular immunity by a biodegradable nanoparticle vaccine.
    Vaccine. 2026;93:129195.
    PubMed         Abstract available

  35. MWASEBA SL, Burger R, von Fintel D
    Beyond disease prevention: rotavirus vaccine rollout and child stunting in Tanzania.
    Vaccine. 2026;93:129210.
    PubMed         Abstract available

  36. BUTLER TL, Anderson K, Morseu-Diop A, Brotherton JML, et al
    Aboriginal and Torres Strait Islander adolescent and parent perspectives on human papillomavirus vaccination through the School Immunisation Program in Queensland, Australia: a qualitative study.
    Vaccine. 2026;93:129170.
    PubMed         Abstract available

  37. SEMPERE L, Almenta I, Barrenengoa J, Gutierrez A, et al
    Corrigendum to 'Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease' [Vaccine 31 (2013) 3065-3071].
    Vaccine. 2026 Sep 28:129140. doi: 10.1016/j.vaccine.2026.129140.
    PubMed        

  38. HYDER S, Melchinger H, Malik F, Kuppalli K, et al
    Trust in government institutions and influenza vaccine acceptance among U.S. adults.
    Vaccine. 2026;93:129212.
    PubMed         Abstract available

  39. SANDERSON K, Robin C, Reynolds R, Hughes G, et al
    Measles, mumps and rubella (MMR) vaccination under-recording in primary care in England: a two-stage cluster survey to inform vaccine optimisation.
    Vaccine. 2026;93:129216.
    PubMed         Abstract available

  40. TSOU TP, Huang YT, Lin CY, Chu PW, et al
    Influenza vaccine effectiveness against influenza-related medical visits, hospitalization and death among adults aged 65 years and older in Taiwan: interim 2024-2025 season result using standard-dose inactivated influenza vaccine.
    Vaccine. 2026;93:129165.
    PubMed         Abstract available

  41. ZHAO JH, Ma QL, Wang WB, Gao PC, et al
    Development of a genetically engineered multivalent subunit vaccine against "struck", "braxy", lamb dysentery, and enterotoxemia in sheep.
    Vaccine. 2026;93:129207.
    PubMed         Abstract available

  42. DING Y, Fu M, Ramachandran R, Yin S, et al
    Public availability and completeness of vaccine product labeling in China.
    Vaccine. 2026;93:129185.
    PubMed         Abstract available

  43. JAYASHANKAR L, DeGrace M, Treanor J, Swanson NJ, et al
    Protection Before Day One: advancing broadly protective seasonal influenza vaccines with pandemic coverage.
    Vaccine. 2026;93:129188.
    PubMed        

  44. BOUYOU-AKOTET MK, Mawili-Mboumba DP
    The Malaria Vaccine Implementation Cascade: From introduction to programme performance.
    Vaccine. 2026;93:129190.
    PubMed        

  45. WILLEMIN T, Guinchard F, Marmey J, Chareyre A, et al
    Corrigendum to "Comprehensive characterization of multivalent mRNA vaccines functionality by flow cytometry and mass spectrometry" [Vaccine 74 (2026) 128180].
    Vaccine. 2026 Sep 30:129184. doi: 10.1016/j.vaccine.2026.129184.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum